Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$11.71 - $30.29 $331,861 - $858,418
-28,340 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$7.64 - $27.5 $27,886 - $100,375
-3,650 Reduced 11.41%
28,340 $387,000
Q4 2019

Feb 11, 2020

SELL
$15.02 - $20.57 $2,253 - $3,085
-150 Reduced 0.47%
31,990 $516,000
Q3 2019

Nov 07, 2019

BUY
$18.85 - $27.5 $605,839 - $883,850
32,140 New
32,140 $619,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.